International Journal of Behavioral Medicine
February 5, 2024
Li Dong, Li Li, Yunlian Wu et al.
18 citations
A systematic review of 14 studies found that psychological interventions, particularly meaning-centered psychotherapy and dignity therapy, can reduce demoralization in patients with chronic diseases. Most studies treated demoralization as a secondary outcome, and ten used randomized controlled designs. Six of these investigated evidence-based meaning-centered therapy, and four investigated dignity therapy, showing the best empirical support. The review concludes that randomized controlled trials with demoralization as the primary outcome and adequate sample sizes are needed to more clearly evaluate effectiveness.
International journal of general medicine
January 1, 2024
Fei-Yi Zhao, Li Li, Peijie Xu et al.
6 citations
A scientometric analysis of 1,549 publications on clinical hypnotherapy from 1994 to 2023 shows a steady annual increase in research output, with an average growth rate of 8.5% and a peak of 134 publications in 2022. The United States is the leading research hub, and collaboration mostly occurs within the same country, institution, or team. High-frequency keywords include "Pain", "Irritable Bowel Syndrome (IBS)", and "Anxiety". Systematic reviews and meta-analyses are common methods, and fMRI and EEG are frequently used to explore neuropsychological mechanisms. Predicted future trends include self-hypnosis, virtual reality hypnotherapy, and comparisons between meditation and hypnotherapy.
BMC anesthesiology
July 1, 2025
Jun-Wei Qi, Chuang Li, Xin-Yuan Qiu et al.
2 citations
Preoperative use of a combination of intranasal dexmedetomidine and esketamine reduces postoperative pain in children undergoing tonsillectomy and adenoidectomy. Among 173 children, the combination group had a lower area under the curve for pain scores at rest within 24 hours (9.50) compared with dexmedetomidine alone (19.25) or saline (37.25). The combination also lowered the incidence of emergence delirium to 12.3% versus 44.8% in the control group. Heart rates were higher in the combination and control groups than in the dexmedetomidine-only group. No serious adverse events occurred.